Okita M, Benfield J R, Jensen T, Matsumura K, Shors E, Cohen A H
J Thorac Cardiovasc Surg. 1977 Feb;73(2):216-20.
We seek to create a canine lung cancer model with sharply localized carcinomas analogous to human lung cancers. Toward this goal techniques for recurrent endobronchial transbronchoscopic submucosal injections and topical applications of the carcinogens 3,4-benzo(a)pyrene and N-methyl-nitrosourea have been developed. After 2 years of experience with 2,868 endoscopic manipulations and varying dosage schedules in 59 dogs, safe effective techniques for recurrently delivering carcinogens and sequential biopsies of the same sites have evolved. Predominantly during the first year of experience, 10 dogs died as a consequence of technical problems such as exsanguinations after 1 mm. punch biopsies. There were also 39 instances of nonlethal technical complications of endoscopy in the face of immunosuppression and local irritation caused by the carcinogens. By the techniques and dosage schedules described, it has now become possible reliably and safely to create impressive localized bronchial preneoplasia with squamous metaplasia and atypia among the prominent features.
我们试图创建一种犬类肺癌模型,使其具有与人类肺癌相似的高度局限性癌。为实现这一目标,已开发出用于反复进行支气管内透支气管黏膜下注射以及局部应用致癌物3,4-苯并(a)芘和N-甲基亚硝基脲的技术。在对59只狗进行了2868次内镜操作并采用不同剂量方案的2年经验之后,已形成了反复递送致癌物以及对同一部位进行连续活检的安全有效技术。主要在经验积累的第一年,有10只狗因技术问题死亡,如在1毫米穿刺活检后失血过多。面对致癌物引起的免疫抑制和局部刺激,内镜检查还出现了39例非致命性技术并发症。通过所描述的技术和剂量方案,现在已经能够可靠且安全地创建出令人印象深刻的局限性支气管肿瘤前期病变,其显著特征包括鳞状化生和异型性。